The effect of enzymatically degradable IPN coatings on peri-implant bone formation and implant fixation

Journal of Biomedical Materials Research - Part A

Volumn 81, Issue 3, 2007, Pages 720-727

  Ho, James E ^a,b   Barber, Thomas A ^a   Virdi, Amarjit S ^c   Sumner, Dale R ^c   Healy, Kevin E ^a,b,c  

^a University of California at Berkeley   (United States)

^b Lawrence Berkeley National Laboratory   (United States)

^c RUSH MEDICAL COLLEGE   (United States)

Author keywords

Degradable; Dual acid etch; Hydroxyapatite tricalcium phosphate; RGD peptide; Titanium

Indexed keywords

BIODEGRADABILITY; BIOMOLECULES; BONE; CALCIUM PHOSPHATE; HYDROXYAPATITE; IMPLANTS (SURGICAL); ORTHOPEDICS; PATIENT TREATMENT; PEPTIDES;

BONE FORMATION; BONE VOLUMES; IMPLANT FIXATION; TRICALCIUM PHOSPHATES;

ENZYME ACTIVITY;

CALCIUM PHOSPHATE; HYDROXYAPATITE; POLYMER;

ANIMAL EXPERIMENT; ARTICLE; BONE REGENERATION; CONTROLLED STUDY; ENZYMATIC DEGRADATION; IMPLANT; MALE; MATERIAL COATING; NONHUMAN; OSSIFICATION; RAT; TOPOGRAPHY;

ANALYSIS OF VARIANCE; ANIMALS; BIOMECHANICS; IMPLANTS, EXPERIMENTAL; MALE; MATRIX METALLOPROTEINASE 13; MICROSCOPY, ELECTRON, SCANNING; OSTEOGENESIS; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; SURFACE PROPERTIES; TIME FACTORS;

EID: 34249023903     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31008     Document Type: Article

References (39)

1. Brånemark P-I. Osseointegration and its experimental studies. J Prosthet Dent 1983;50:399-410.
2. Mahomed NN, Barrett JA, Katz JN, Phillips CB, Losina E, Lew RA, Guadagnoli E, Harris WH, Poss R, Baron JA. Rates and outcomes of primary and revision total hip replacement in the United States medicare population. J Bone Joint Surg Am 2003;85:27-32.
3. Cook SD, Thomas KF, Dalton JE. Hydroxylapatite coating of porous implants improves bone ingrowth and interface attachment strength. J Biomed Mater Res 1992;26:989-1001.
4. Geesink RG, Hoefnagels NH. Six-year results of hydroxyapatite-coated total hip replacement. J Bone Joint Surg Br 1995;77:534-547.
5. Walenciak MT, Zimmerman MC, Harten RD, Ricci JL, Stamer DT. Biomechanical and histological analysis of an HA coated, arc deposited CPTi canine hip prosthesis. J Biomed Mater Res 1996;31:465-474.
6. Wong M, Eulenberger J, Schenk R, Hunziker E. Effect of surface topology on the osseointegration of implant materials in trabecular bone. J Biomed Mater Res 1995;29:1567-1575.
7. Hacking SA, Tanzer M, Harvey EJ, Krygier JJ, Bobyn JD. Relative contributions of chemistry and topography to the osseointegration of hydroxyapatite coatings. Clin Orthop 2002;405:24-38.
8. Aebli N, Krebs J, Stich H, Schawalder P, Walton M, Schwenke D, Gruner H, Gasser B, Theis JC. In vivo comparison of the osseointegration of vacuum plasma sprayed titanium- and hydroxyapatite-coated implants. J Biomed Mater Res A 2003;66:356-363.
9. Barber TA, Ho JE, De Ranieri A, Virdi AS, Sumner DR, Healy KE. Peri-implant bone formation and implant integration strength of peptide-modified p(AAm-co-EG/AAc) IPN coated titanium implants. J Biomed Mater Res A 2006; E-pub ahead of print.
10. Kuroda S, Virdi AS, Li P, Healy KE, Sumner DR. A low-temperature biomimetic calcium phosphate surface enhances early implant fixation in a rat model. J Biomed Mater Res A 2004;70:66-73.
11. Barber TA, Gamble LJ, Castner DG, Healy KE. In vitro characterization of peptide-modified p(AAm-co-EG/AAc) IPN-coated titanium implants. J Orthop Res 2006;24:1366-1376.
12. Rezania A, Thomas CH, Branger AB, Waters CM, Healy KE. The detachment strength and morphology of bone cells contacting materials modified with a peptide derived from bone sialoprotein. J Biomed Mater Res 1997;37:9-19.
13. Rezania A, Healy KE. Biomimetic peptide surfaces that regulate adhesion, spreading, cytoskeletal organization, and mineralization of the matrix deposited by osteoblast-like cells. Biotechnol Prog 1999;15:19-32.
14. Rezania A, Healy KE. The effect of peptide surface density on the mineralization of matrix deposited by osteogenic cells. J Biomed Mater Res 2000;52:595-600.
15. Sigurdsson TJ, Fu E, Tatakis DN, Rohrer MD, Wikesjo UM. Bone morphogenetic protein-2 for peri-implant bone regeneration and osseointegration. Clin Oral Implants Res 1997;8:367-374.
16. Sumner DR, Turner TM, Urban RM, Turek T, Seeherman H, Wozney JM. Locally delivered rhBMP-2 enhances bone growth and gap healing in canine model. J Orthop Res 2004;22:58-65.
17. Cochran DL, Schenk R, Buser D, Wozney JM, Jones AA. Recombinant human bone morphogenetic protein-2 stimulation of bone formation around endosseous dental implants. J Periodontol 1999;70:139-150.
18. Harbers GM, Healy KE. The effect of ligand type and density on osteoblast adhesion, proliferation, and matrix mineralization. J Biomed Mater Res A 2005;75:855-869.
19. Pierschbacher MD, Ruoslahti E. New perspectives in cell adhesion: RGD and integrins. Science 1987;238:491-497.
20. Bellahcene A, Bonjean K, Fohr B, Fedarko NS, Robey FA, Young MF, Fisher LW, Castronovo V. Bone sialoprotein mediates human endothelial cell attachment and migration and promotes angiogenesis. Circ Res 2000;86:885-891.
21. Shubayev VI, Branemark R, Steinauer J, Myers RR. Titanium implants induce expression of matrix metalloproteinases in bone during osseointegration. J Rehabil Res Dev 2004;41(6, Part A):757-766.
22. Beaty KD. Implant surface preparation utilizing acid treatment. US Patent 5,603,338; 1997.
23. Beaty KD. Implant surface preparation. US Patent 5,876,453; 1999.
24. Kim S, Healy KE. Synthesis and characterization of injectable poly(N-isopropylacrylamide-co-acrylic acid) hydrogels with proteolytically degradable cross-links. Biomacromolecules 2003;4:1214-1223.
25. Bearinger JP, Castner DG, Healy KE. Biomolecular modification of p(AAm-co-EG/AA) IPNs support osteoblast adhesion and phenotypic expression. J Biomater Sci Polym Ed 1998;9:629-652.
26. Kuroda S, Virdi AS, Dai Y, Shott S, Sumner DR. Patterns and localization of gene expression during intramembranous bone regeneration in the rat femoral marrow ablation model. Calcif Tissue Int 2005;77:212-225.
27. De Ranieri A, Virdi AS, Kuroda S, Healy KE, Hallab NJ, Sumner DR. Saline irrigation does not affect bone formation or fixation strength of hydroxyapatite/tricalcium phosphate-coated implants in a rat model. J Biomed Mater Res B Appl Biomater 2005;74:712-717.
28. De Ranieri A, Virdi AS, Kuroda S, Shott S, Leven RM, Hallab NJ, Sumner DR. Local application of rhTGF-β2 enhances peri-implant bone volume and bone-implant contact in a rat model. Bone 2005;37:55-62.
29. Elmengaard B, Bechtold JE, Soballe K. In vivo effects of RGD-coated titanium implants inserted in two bone-gap models. J Biomed Mater Res A 2005;75:249-255.
30. Ferris DM, Moodie GD, Dimond PM, Gioranni CW, Ehrlich MG, Valentini RF. RGD-coated titanium implants stimulate increased bone formation in vivo. Biomaterials 1999;20:2323-2331.
31. Schliephake H, Scharnweber D, Dard M, Rossler S, Sewing A, Meyer J, Hoogestraat D. Effect of RGD peptide coating of titanium implants on periimplant bone formation in the alveolar crest: An experimental pilot study in dogs. Clin Oral Implants Res 2002;13:312-319.
32. Elmengaard B, Bechtold JE, Soballe K. In vivo study of the effect of RGD treatment on bone ongrowth on press-fit titanium alloy implants. Biomaterials 2005;26:3521-3526.
33. Suva LJ, Seedor JG, Endo N, Quartuccio HA, Thompson DD, Bab I, Rodan GA. Pattern of gene expression following rat tibial marrow ablation. J Bone Miner Res 1993;8:379-388.
34. Abron A, Hopfensperger M, Thompson J, Cooper LF. Evaluation of a predictive model for implant surface topography effects on early osseointegration in the rat tibia model. J Prosthet Dent 2001;85:40-46.
35. Reikeras O, Johansson CB, Sundfeldt M. Hydroxyapatite and carbon coatings for fixation of unloaded titanium implants. J Long Term Eff Med Implants 2004;14:443-454.
36. Lohmann CH, Sagun RJ, Sylvia VL, Cochran DL, Dean DD, Boyan BD, Schwartz Z. Surface roughness modulates the response of MG63 osteoblast-like cells to 1,25-(OH)2D3 through regulation of phospholipase A2 activity and activation of protein kinase A. J Biomed Mater Res 1999;47:139-151.
37. 2 blasted titanium implant material for attachment, proliferation and differentiation of cells derived from human mandibular alveolar bone. Clin Oral Implants Res 2001;12:515-525.
38. Korovessis PG, Deligianni DD. Role of surface roughness of titanium versus hydroxyapatite on human bone marrow cells response. J Spinal Disord Tech 2002;15:175-183.
39. Baker DA, London RM, O'Neal RB. Rate of pull-out strength gain of dual-etched titanium implants: A comparative study in rabbits. Int J Oral Maxillofac Implants 1999;14:722-728.